Variant report
Variant | nsv982202 |
---|---|
Chromosome Location | chr9:21420183-21420683 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr9:21420220-21420370 | GM12875 | blood: | n/a | n/a |
2 | CTCF | chr9:21420260-21420410 | GM12878 | blood: | n/a | n/a |
3 | CTCF | chr9:21420320-21420470 | A549 | lung: | n/a | n/a |
4 | POLR2A | chr9:21420433-21420490 | Hela-S3 | cervix: | n/a | n/a |
5 | POLR2A | chr9:21420405-21420533 | A549 | lung: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IFNA8-2 | chr9:21420233-21420812 | NONHSAT130384 |
No data |
No data |
Variant related genes | Relation type |
---|---|
IFNWP2 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531889156 | chr9:21420189-21420190 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs552073572 | chr9:21420210-21420211 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs187954185 | chr9:21420234-21420235 | Enhancers Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs139574910 | chr9:21420235-21420236 | Enhancers Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs527689274 | chr9:21420247-21420248 | Enhancers Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs142866724 | chr9:21420314-21420315 | Enhancers Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs77417532 | chr9:21420344-21420345 | Enhancers Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs530177072 | chr9:21420345-21420346 | Enhancers Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs116570402 | chr9:21420369-21420370 | Enhancers Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs192041624 | chr9:21420372-21420373 | Enhancers Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs538404494 | chr9:21420388-21420389 | Enhancers Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs537712479 | chr9:21420404-21420405 | Enhancers Bivalent Enhancer Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs556751886 | chr9:21420443-21420444 | Enhancers Bivalent Enhancer Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs532576939 | chr9:21420446-21420447 | Enhancers Bivalent Enhancer Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs371955631 | chr9:21420461-21420462 | Enhancers Bivalent Enhancer Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs558039230 | chr9:21420482-21420483 | Enhancers Bivalent Enhancer Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs527613547 | chr9:21420535-21420536 | Enhancers Bivalent Enhancer Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs375067502 | chr9:21420554-21420555 | Enhancers Bivalent Enhancer Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs533766003 | chr9:21420607-21420608 | Bivalent Enhancer Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs553842355 | chr9:21420644-21420645 | Bivalent Enhancer Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs573763166 | chr9:21420652-21420653 | Bivalent Enhancer Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs542735884 | chr9:21420673-21420674 | Bivalent Enhancer Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs1332179 | chr9:21420677-21420678 | Bivalent Enhancer Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Cancer | 22183965 | CNVD |
Glioblastoma multiforme | 21569311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Lung cancer | 21911935 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
head and neck squamous cell carcinoma | 21798897 | CNVD |
Cancer | 21253487 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Leukemia | 19602459 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Glioma | 20126413 | CNVD |
Melanoma | 17363583 | CNVD |
Glioblastoma multiforme | 19115005 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20581869 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
Oral cancer | 22144094 | CNVD |
Lung cancer | 21569311 | CNVD |
Epilepsy | 20502679 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:21414800-21420200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr9:21415800-21420200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr9:21418800-21420400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr9:21419000-21420600 | Enhancers | Muscle Satellite Cultured Cells | -- |
5 | chr9:21419600-21420200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr9:21420200-21420600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr9:21420200-21420800 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
8 | chr9:21420200-21420800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr9:21420200-21421400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr9:21420400-21421200 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |